Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20877624 | 0.74 | F2 (0.36) | F2 | |
| SCHEMBL23752578 | 0.72 | F2 (1.00) | F2 | |
| SCHEMBL1878001 | 0.71 | ALDH1A1 (0.32) | F2 | |
| SCHEMBL27369711 | 0.70 | — | — | |
| SCHEMBL13701168 | 0.69 | F2 (0.42) | F2 | |
| SCHEMBL16765955 | 0.68 | F2 (0.43) | F2 | |
| SCHEMBL7063103 | 0.64 | F2 (0.35) | F2 | |
| SCHEMBL19029406 | 0.61 | — | — | |
| SCHEMBL1274061 | 0.60 | — | — | |
| SCHEMBL1274063 | 0.60 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11446398-B2 | Regulated biocircuit systems | OBSIDIAN THERAPEUTICS, INC. (US) | 2022-09-20 | — | — | US | disclosed |
| US-20210254056-A1 | IDENTIFICATION AND TARGETED MODULATION OF GENE SIGNALING NETWORKS | CAMP4 THERAPEUTICS CORPORATION | 2021-08-19 | — | — | US | disclosed |
| US-20190192691-A1 | REGULATED BIOCIRCUIT SYSTEMS | OBSIDIAN THERAPEUTICS, INC. | 2019-06-27 | — | — | US | disclosed |